is tirzepatide similar to ozempic vs Semaglutide: A Weight Loss Showdown FDA accepts generic tirzepatide bids

OSA is a highly prevalent condition, strongly associated with obesity and linked to an increased risk of cardiovascular disease

In this Review, Cowie and Fisher describe the additional mechanisms of benefit of SGLT2 inhibitors, unrelated to improved glycaemic control.

Understanding the biological mechanisms and practical management techniques can help you navigate this side effect and stay on track with your weight loss goals

Tirzepatide Microdose delivers the dual GLP-1 and GIP action of tirzepatide at a lower starting dose a gentler introduction for those new to dual-action GLP-1+GIP therapy.

Consult un expert online

Outcomes form the STEER real-world study have revealed that semaglutide 2.4 mg had 57% greater risk reduction for heart attack, stroke and cardiovascular-related death or death from any cause, in people with overweight or obesity and CVD, who did not have any gaps in their treatment lasting more than 30 days, compared with tirzepatide